C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
10/2006
10/18/2006	CN1849356A Polymer complex compound and polymeric luminescent element employing the same
10/18/2006	CN1849312A Tocopherol derivatives with a long hydroxylated chain, which can be used as neurotrophics
10/18/2006	CN1849117A Entry inhibitors of the HIV virus
10/18/2006	CN1847235A Simple prepn process of gibberellin GA
10/18/2006	CN1847234A Tetrahydro furfuryl alcohol preparing process
10/18/2006	CN1280282C Method for producing phthalides
10/18/2006	CN1280281C Hydrogenation of 3,4-tetrahydrofurandiol to tetrahydrofuran
10/18/2006	CN1280272C Spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
10/18/2006	CN1280271C Arylphenyl-substituted cyclic keto-enols
10/18/2006	CN1280267C Sulfonylaminocarboxylic acids
10/18/2006	CN1280266C Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
10/18/2006	CN1280258C Process for producing 4,5-diamino shikimic acid derivative
10/17/2006	US7122687 Sodium salt formation of Mycophenolic acid
10/17/2006	US7122685 For use in ink jet printer ink
10/17/2006	US7122678 (Trans)-(3,4-Dimethyl-cyclopentyldine)-acetic acid ethyl ester; treating epilepsy, faintness attacks, hypokinesia, cranial disorders, neurodegenerative disorders, depression, anxiety, panic, pain, neuropathological disorders, irritable bowel syndrome (IBS), and inflammation
10/17/2006	US7122661 treatment with an ion-exchanging means; subsequent decoloration treatment; for isohexide compositions, in particular isosorbide or isomannide.
10/17/2006	US7122580 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc
10/17/2006	US7122571 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/17/2006	US7122561 Treatment of skin conditions
10/17/2006	US7122536 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
10/17/2006	US7122228 Compound having negative Δε
10/17/2006	CA2318527C Inhibitors of .alpha.4 mediated cell adhesion
10/17/2006	CA2253547C Benzofuryl derivatives and their use
10/12/2006	WO2006107027A1 Agent for prevention or treatment of nocturnal behavioral disorder associated with dementia
10/12/2006	WO2006107019A1 Preventive or remedy for depression or anxiety neurosis
10/12/2006	WO2006106778A1 Bcrp/abcg2 inhibitor
10/12/2006	WO2006106531A1 Process for the preparation of escitalopram or its acid addition salts
10/12/2006	WO2006066879A3 Compounds with kv4 ion channel activity
10/12/2006	WO2005095326A8 2-amino- and 2-thio-substituted 1,3-diaminopropanes
10/12/2006	US20060229459 Crystalline base of citalopram
10/12/2006	US20060229458 Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran
10/12/2006	US20060229446 Structural carotenoid analogs for the inhibition and amelioration of disease
10/12/2006	US20060229385 9-Cyano-Substituted Perylene-3, 4-Dicarboxylic Monoimides
10/12/2006	US20060229357 Compounds
10/12/2006	US20060229304 (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesterol ester transfer protein activity
10/12/2006	CA2602467A1 Bcrp/abcg2 inhibitor
10/12/2006	CA2601988A1 Prophylactic or therapeutic agent for noctural conduct disorder associated with dementia
10/11/2006	EP1710238A1 Benzophenones as inhibitors of reverse transcriptase
10/11/2006	EP1710231A1 CETP activity inhibitors
10/11/2006	EP1710230A1 Novel sulfonate salts and derivatives, photoacid generators, resist compositions, and patterning process
10/11/2006	EP1709964A2 A method of cosmetic depigmentation care by applying at least one aurone
10/11/2006	EP1709037A2 Hiv protease inhibiting sulfonamides
10/11/2006	EP1709029A2 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
10/11/2006	EP1709027A1 Hydrazide type compounds and the use thereof in pharmaceutical compositions for the treatment of cardiovascular diseases
10/11/2006	EP1709026A1 Aqueous polymer dispersions containing alkenyl succinic acid anhydrides, methods for the production thereof, and use of the same
10/11/2006	EP1709022A1 Selective estrogen receptor modulators
10/11/2006	EP1708702A2 Novel m3 muscarinic acetylcholine receptor antagonists
10/11/2006	EP1478629B1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
10/11/2006	EP1246696B1 Oxidative reactions using membranes that selectively conduct oxygen
10/11/2006	CN1845914A Ophthalmic compositions for treating ocular hypertension
10/11/2006	CN1844125A Method for extracting bilobalide B from ginkgo leaf or ginkgo leaf extract
10/11/2006	CN1844114A Fukinanolide compounds and pharmaceutical application thereof
10/11/2006	CN1844113A Hydroxy tanshinone IIA sodium sulfonate and its application
10/11/2006	CN1279043C Novel type sugar of C12 high carbon, its derivative, preparation method and application
10/10/2006	US7119229 Having anticancer, anti-proliferous and anti-inflammatory effects and immunosuppressive and muscle relaxing functions
10/10/2006	US7119215 1,3-dimethyl-4-(4'-fluorobenzoyl)benzene as a starting material for antidepressants
10/10/2006	US7119214 dibenzofuranyl, dibenzothiophenyl or fluorenyl thioacetamides used for prophylaxis of sleep disorders
10/10/2006	US7119208 drugs that bind to and increases oxygen affinity of hemoglobin, and preventing polymerization and formation fibrous precipitates hemoglobin, used for treatment of sickle-cell disease
10/10/2006	US7119198 beta-aryl-alpha-oxysubstituted alkylcarboxylic acids, usch as Ethyl (E/Z)-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropenoate, used as antilipemic or hypoglycemic agents
10/10/2006	US7119120 A 2-benzenesulfonylamino-N-benzyl-benzamides for treating hyperphosphatemia, urogential disorders
10/10/2006	US7119112 Sulfonamides as potassium channel blockers
10/10/2006	US7119099 DNA replication that interfere with the E1-E2-DNA complex during initiation of DNA replication; 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives
10/10/2006	US7119085 Inhibit amyloid protein deposits
10/10/2006	US7119080 Boronic ester and acid compounds, synthesis and uses
10/10/2006	US7118899 Introducing a reagent comprising a hydrophobic fluorescent ion; measuring energy transfer
10/10/2006	CA2359046C Heterocyclically anellated indenochromene derivatives
10/10/2006	CA2255912C Process for preparing gamma-butyrolactone, butane-1,4-diol and tetrahydrofuran
10/10/2006	CA2253407C Inorganic ion receptor-active compounds
10/10/2006	CA2158862C Taxanes having alkoxy, alkenoxy or aryloxy substituted side-chain and pharmaceutical compositions containing same
10/06/2006	CA2560740A1 Synthesis of rocaglamide natural products via photochemical generation of oxidopyrylium species
10/05/2006	WO2006105127A2 Hydroxysteroid dehydrogenase inhibitors
10/05/2006	WO2006103550A1 Processes for the preparation of citalopram and its intermediate 5-aminophthalide
10/05/2006	WO2006103401A2 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
10/05/2006	WO2006102789A1 Ferula fukanensis extract, the preperation method and the use in producing medicine thereof
10/05/2006	WO2006086374A3 3-amino-2-aminomethylphenol derivatives and colorants comprising these compounds
10/05/2006	WO2006071609A3 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/05/2006	WO2004060308A3 Thiosemicarbazones as anti-virals and immunopotentiators
10/05/2006	US20060223763 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans
10/05/2006	CA2602075A1 N-alkylcarbonyl-amino acid ester and n-alkylcarbonyl-amino lactone compounds and their use
10/04/2006	EP1707556A1 Method of enantiometrically selective nucleophilic addition reaction to carbonyl of enamide and method of synthesizing optically active alpha-hydroxy-gamma-keto acid ester and hydroxydiketone
10/04/2006	EP1706402A1 Cathepsin cysteine protease inhibitors
10/04/2006	EP1706395A1 Thiophene and furan compounds
10/04/2006	EP1706394A1 Preparation of escitalopram
10/04/2006	EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
10/04/2006	EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/04/2006	EP1097382B1 Imidazoline receptor binding compounds
10/04/2006	CN1842528A Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
10/04/2006	CN1842523A Process for the asymmetric hydrogenation of beta-amino ketones
10/04/2006	CN1842517A 芴衍生物 Fluorene derivatives
10/04/2006	CN1842515A Cathepsin inhibitors
10/04/2006	CN1277831C Composition of ginkgo internal ester B and its preparation and use thereof
10/04/2006	CN1277825C Lactone derivative, and plant growth regulator and rooting agent each containing the same as active ingredient
10/04/2006	CN1277824C Piperazine derivatives
10/04/2006	CN1277787C Optical dividing method for sclare lactone precursor
10/03/2006	US7115784 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
10/03/2006	US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents
10/03/2006	US7115757 1,2-dioxetane derivatives and reagents employing them
10/03/2006	US7115752 Substituted cyclic compounds
10/03/2006	US7115750 Melanin concentrating hormone antagonist
10/03/2006	US7115661 Methods and compositions for mitigating pain

1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 472